You just read:

Ervaxx and Cardiff University Enter Collaboration to Develop Novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens™

News provided by

Ervaxx

Jan 24, 2020, 03:00 ET